U.S. President Donald Trump said in a post on Truth Social on Tuesday that the U.S. and Iran deal negotiations are ongoing, dismissing reports of strained relations between the two countries.
U.S. President Donald Trump said in a post on Truth Social on Tuesday that the U.S. and Iran deal negotiations are ongoing, dismissing reports of strained relations between the two countries.
S&P 500, Nasdaq, Dow Futures Ease After Another Record Close As AI Momentum Cushions Iran's Expanding Strikes: MRVL, AVGO, MSFT, PANW In Focus Yahoo Finance
S&P 500, Nasdaq, Dow Futures Ease After Another Record Close As AI Momentum Cushions Iran's Expanding Strikes: MRVL, AVGO, MSFT, PANW In Focus Yahoo Finance
Mohammed Haneefa Nizamudeen/iStock via Getty Images Madrigal Pharmaceuticals, Inc. ( MDGL ) was founded in 2016 and is headquartered in West Conshohocken, PA. It describes itself as "a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need." Note that MASH used to be called NASH, r...
Mohammed Haneefa Nizamudeen/iStock via Getty Images Madrigal Pharmaceuticals, Inc. ( MDGL ) was founded in 2016 and is headquartered in West Conshohocken, PA. It describes itself as "a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need." Note that MASH used to be called NASH, referring to non-alcoholic steatohepatitis. It’s the same disease, just renamed. Madrigal has one drug on the market, Rezdiffra, a liver-directed thyroid hormone receptor beta agonist, which helps to reduce liver fat accumulation, that was approved by the FDA in March 2024 and by the EMA in August 2025 . Rezdiffra From an investment perspective, the fact that Madrigal has just one focus for its pharmaceutical products makes it high risk/high reward, meaning that if it does not excel in this one area, it could become, in essence, obsolete. Shareholders would suffer tremendously in this case. Conversely, they could become the next Vertex Pharmaceuticals ( VRTX ), which put all its eggs in the Cystic Fibrosis basket in the mid-2000s and now, with five successful approvals in CF alone and several blockbuster drugs, has grown to become one of the largest pharmaceutical companies in the world, with a market cap of over $110 billion. Their initial focus in CF – and the cash flow that their treatments have generated – has afforded them opportunities to expand into new disease treatment areas. Does Madrigal, with a shot at dominating in MASH, have the potential to become the next Vertex? From an analyst's perspective, the fact that Madrigal has just one key focus helps to simplify things, at least theoretically, as compared to companies like Roche ( RHHBY ) or GSK ( GSK ) with literally dozens of different medications on the market and in their pipeline. This makes it difficult to assess which, if any, will truly move the needle or, conversely, become a drag on profitability. For Mad...
The U.S. Supreme Court is seen on May 28, 2026 in Washington, DC. Kevin Dietsch | Getty Images The Supreme Court on Tuesday night said it would allow the state of Alabama to use a new map for congressional districts that a lower federal court had ruled was discriminatory to Black voters. The 6-3 ruling by the Supreme Court is expected to result in Republicans in Alabama gaining one seat in the Hou...
The U.S. Supreme Court is seen on May 28, 2026 in Washington, DC. Kevin Dietsch | Getty Images The Supreme Court on Tuesday night said it would allow the state of Alabama to use a new map for congressional districts that a lower federal court had ruled was discriminatory to Black voters. The 6-3 ruling by the Supreme Court is expected to result in Republicans in Alabama gaining one seat in the House of Representatives in November's midterm elections because of the dilution of Black voters in the district. Republicans hold a razor-thin majority in the House of Representatives. Since last year that have forced redistrictings in a number of states in an effort to retain that majority in the upcoming elections, which in turn led to identical efforts by Democrats in other states. Tuesday's decision by the Supreme Court overturns a ruling issued May 26 by a panel of three judges in U.S. District Court in Birmingham, Ala., which found that the state's map proposed in 2023 "intentionally discriminated based on race." That panel had been compelled to revisit a prior decision barring the map from being used in state elections in light of a recent Supreme Court ruling in the case known as Louisiana v. Callais. The Supreme Court in that case found that Louisiana's drawing of its own congressional maps was a racial gerrymander. This is breaking news. Please refresh for updates. Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
(RTTNews) - Texas Instruments Inc. (TXN) announced that it has appointed Julie Knecht as chief financial officer, effective August 1, 2026. Knecht succeeds Rafael Lizardi, who will retire after 25 years with the company. Lizardi will provide continued support in an advisory role
(RTTNews) - Texas Instruments Inc. (TXN) announced that it has appointed Julie Knecht as chief financial officer, effective August 1, 2026. Knecht succeeds Rafael Lizardi, who will retire after 25 years with the company. Lizardi will provide continued support in an advisory role
He is already the richest man in the world, but when SpaceX finally makes its hotly anticipated stock market debut, Elon Musk could become the planet's first trillionaire.Robinson said Musk could take on an "aura of God" for some people should he become the world's first trillionaire -- but might develop a bit of a god complex himself as a result.
He is already the richest man in the world, but when SpaceX finally makes its hotly anticipated stock market debut, Elon Musk could become the planet's first trillionaire.Robinson said Musk could take on an "aura of God" for some people should he become the world's first trillionaire -- but might develop a bit of a god complex himself as a result.